Prestige Wealth Management Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$54.8K Sell
135
-1
-0.7% -$406 0.01% 245
2025
Q1
$67.7K Hold
136
0.01% 227
2024
Q4
$70.8K Hold
136
0.01% 227
2024
Q3
$84.2K Buy
136
+75
+123% +$46.4K 0.02% 205
2024
Q2
$33.8K Buy
61
+6
+11% +$3.32K 0.01% 261
2024
Q1
$32K Hold
55
0.01% 292
2023
Q4
$29.2K Sell
55
-18
-25% -$9.56K 0.01% 296
2023
Q3
$37K Buy
73
+11
+18% +$5.57K 0.01% 266
2023
Q2
$32.4K Sell
62
-1,124
-95% -$587K 0.01% 303
2023
Q1
$684K Buy
1,186
+1,116
+1,594% +$644K 0.17% 64
2022
Q4
$38.6K Sell
70
-976
-93% -$538K 0.01% 277
2022
Q3
$531K Buy
1,046
+109
+12% +$55.3K 0.15% 67
2022
Q2
$510K Buy
937
+6
+0.6% +$3.27K 0.14% 71
2022
Q1
$550K Buy
931
+871
+1,452% +$515K 0.14% 74
2021
Q4
$40K Buy
60
+7
+13% +$4.67K 0.01% 284
2021
Q3
$30K Buy
53
+8
+18% +$4.53K 0.01% 312
2021
Q2
$23K Buy
45
+2
+5% +$1.02K 0.01% 345
2021
Q1
$20K Sell
43
-1
-2% -$465 0.01% 364
2020
Q4
$20K Sell
44
-111
-72% -$50.5K 0.01% 358
2020
Q3
$69K Hold
155
0.02% 207
2020
Q2
$56K Sell
155
-219
-59% -$79.1K 0.02% 211
2020
Q1
$106K Buy
374
+263
+237% +$74.5K 0.04% 121
2019
Q4
$36K Sell
111
-7
-6% -$2.27K 0.02% 228
2019
Q3
$34K Buy
118
+8
+7% +$2.31K 0.02% 226
2019
Q2
$32K Hold
110
0.02% 225
2019
Q1
$30K Sell
110
-103
-48% -$28.1K 0.02% 226
2018
Q4
$48K Buy
+213
New +$48K 0.04% 197